Published in Cell on August 17, 2012
Microenvironmental regulation of tumor progression and metastasis. Nat Med (2013) 8.37
Tumor metastasis: moving new biological insights into the clinic. Nat Med (2013) 2.71
Origins of metastatic traits. Cancer Cell (2013) 2.49
Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer (2014) 2.09
Tumor cell dissemination: emerging biological insights from animal models and cancer patients. Cancer Cell (2013) 2.08
Metastatic stem cells: sources, niches, and vital pathways. Cell Stem Cell (2014) 1.88
Mechanisms governing metastatic dormancy and reactivation. Cell (2013) 1.81
Beyond TGFβ: roles of other TGFβ superfamily members in cancer. Nat Rev Cancer (2013) 1.67
Glioma cancer stem cells secrete Gremlin1 to promote their maintenance within the tumor hierarchy. Genes Dev (2014) 1.57
TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling. Nat Cell Biol (2013) 1.50
Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow. Nat Cell Biol (2016) 1.43
Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT. Cell (2016) 1.36
Metastatic colonization by circulating tumour cells. Nature (2016) 1.31
TGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis. J Oncol (2015) 1.23
Metastasis dormancy in estrogen receptor-positive breast cancer. Clin Cancer Res (2013) 1.15
The dormancy dilemma: quiescence versus balanced proliferation. Cancer Res (2013) 1.04
Metastasis prevention by targeting the dormant niche. Nat Rev Cancer (2015) 1.03
Epithelial-mesenchymal plasticity of breast cancer stem cells: implications for metastasis and therapeutic resistance. Curr Pharm Des (2015) 1.01
Cripto-1 as a novel therapeutic target for triple negative breast cancer. Oncotarget (2015) 1.01
c-Jun N-Terminal Kinases Mediate a Wide Range of Targets in the Metastatic Cascade. Genes Cancer (2013) 0.98
Molecular pathways: niches in metastatic dormancy. Clin Cancer Res (2014) 0.95
Metastasis awakening: targeting dormant cancer. Nat Med (2013) 0.94
Emerging Biological Principles of Metastasis. Cell (2017) 0.94
The DAN family: modulators of TGF-β signaling and beyond. Protein Sci (2014) 0.91
Multi-organ Site Metastatic Reactivation Mediated by Non-canonical Discoidin Domain Receptor 1 Signaling. Cell (2016) 0.91
Distinctive properties of metastasis-initiating cells. Genes Dev (2016) 0.91
Surviving at a distance: organ specific metastasis. Trends Cancer (2015) 0.90
Inhibition of BMP signaling suppresses metastasis in mammary cancer. Oncogene (2014) 0.90
The biology of circulating tumor cells. Oncogene (2015) 0.90
Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment. Oncogene (2015) 0.86
Structure of neuroblastoma suppressor of tumorigenicity 1 (NBL1): insights for the functional variability across bone morphogenetic protein (BMP) antagonists. J Biol Chem (2015) 0.84
Vaccinia virus expressing bone morphogenetic protein-4 in novel glioblastoma orthotopic models facilitates enhanced tumor regression and long-term survival. J Transl Med (2013) 0.84
Concise review: breast cancer stem cells: regulatory networks, stem cell niches, and disease relevance. Stem Cells Transl Med (2014) 0.83
Cancer cells enter dormancy after cannibalizing mesenchymal stem/stromal cells (MSCs). Proc Natl Acad Sci U S A (2016) 0.83
Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization. Genes Dev (2016) 0.83
Forward genetic screens in mice uncover mediators and suppressors of metastatic reactivation. Proc Natl Acad Sci U S A (2014) 0.82
Tumour cells coerce host tissue to cancer spread. Bonekey Rep (2013) 0.82
Mechanisms involved in breast cancer liver metastasis. J Transl Med (2015) 0.82
Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow. Sci Rep (2016) 0.81
The biology and clinical implications of prostate cancer dormancy and metastasis. J Mol Med (Berl) (2015) 0.81
Glioblastoma Circulating Cells: Reality, Trap or Illusion? Stem Cells Int (2015) 0.81
The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer. Oncotarget (2016) 0.81
Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis. Oncotarget (2015) 0.81
Metastasis: Recharging with COCO. Nat Rev Cancer (2012) 0.81
Metastasis: an early event in cancer progression. J Cancer Res Clin Oncol (2016) 0.81
BMP/Coco antagonism as a deterministic factor of metastasis dormancy in lung. Breast Cancer Res (2013) 0.80
Structure of Gremlin-2 in Complex with GDF5 Gives Insight into DAN-Family-Mediated BMP Antagonism. Cell Rep (2016) 0.80
Future Perspective of Single-Molecule FRET Biosensors and Intravital FRET Microscopy. Biophys J (2016) 0.80
Sphere-derived tumor cells exhibit impaired metastasis by a host-mediated quiescent phenotype. Oncotarget (2015) 0.80
The role of the microenvironment-dormant prostate disseminated tumor cells in the bone marrow. Drug Discov Today Technol (2014) 0.80
The emerging molecular machinery and therapeutic targets of metastasis. Trends Pharmacol Sci (2015) 0.80
Coco is a dual activity modulator of TGFβ signaling. Development (2015) 0.80
Tumor dormancy: potential therapeutic target in tumor recurrence and metastasis prevention. Exp Hematol Oncol (2013) 0.79
Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growth. Cancer Lett (2015) 0.79
An integrated genomic approach identifies persistent tumor suppressive effects of transforming growth factor-β in human breast cancer. Breast Cancer Res (2014) 0.79
BMPR2 loss in fibroblasts promotes mammary carcinoma metastasis via increased inflammation. Mol Oncol (2014) 0.79
The BMP inhibitor DAND5 in serum predicts poor survival in breast cancer. Oncotarget (2016) 0.79
Tumor microenvironment: driving forces and potential therapeutic targets for breast cancer metastasis. Chin J Cancer (2017) 0.78
Downregulation of CXCR4 in Metastasized Breast Cancer Cells and Implication in Their Dormancy. PLoS One (2015) 0.78
Inflammation Triggers Zeb1-Dependent Escape from Tumor Latency. Cancer Res (2016) 0.77
SMAD signaling and redox imbalance cooperate to induce prostate cancer cell dormancy. Cell Cycle (2015) 0.77
SMURF1 silencing diminishes a CD44-high cancer stem cell-like population in head and neck squamous cell carcinoma. Mol Cancer (2014) 0.77
The dual role of asporin in breast cancer progression. Oncotarget (2016) 0.77
p38γ MAPK Is a Therapeutic Target for Triple-Negative Breast Cancer by Stimulation of Cancer Stem-Like Cell Expansion. Stem Cells (2015) 0.77
Smad6 determines BMP-regulated invasive behaviour of breast cancer cells in a zebrafish xenograft model. Sci Rep (2016) 0.76
BMP Antagonist Gremlin 2 Limits Inflammation After Myocardial Infarction. Circ Res (2016) 0.76
New insights into tumor dormancy: Targeting DNA repair pathways. World J Clin Oncol (2015) 0.76
Integrative analysis of transcriptional regulatory network and copy number variation in intrahepatic cholangiocarcinoma. PLoS One (2014) 0.76
Circulating and disseminated tumor cells: harbingers or initiators of metastasis? Mol Oncol (2017) 0.76
Means to the ends: The role of telomeres and telomere processing machinery in metastasis. Biochim Biophys Acta (2016) 0.75
Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis. Oncotarget (2016) 0.75
Coco expression in lung promotes organ-specific metastasis. Bonekey Rep (2012) 0.75
c-Abl inhibits breast cancer tumorigenesis through reactivation of p53-mediated p21 expression. Oncotarget (2016) 0.75
Chordin-Like 1 Suppresses Bone Morphogenetic Protein 4-Induced Breast Cancer Cell Migration and Invasion. Mol Cell Biol (2016) 0.75
The Relationship Between Dormant Cancer Cells and Their Microenvironment. Adv Cancer Res (2016) 0.75
GALNT14 promotes lung-specific breast cancer metastasis by modulating self-renewal and interaction with the lung microenvironment. Nat Commun (2016) 0.75
Adaptive Stress Responses During Tumor Metastasis and Dormancy. Trends Cancer (2016) 0.75
Elevated serum DAND5 is associated with metastasis and predicts poor prognosis in colorectal cancer. United European Gastroenterol J (2016) 0.75
Tumor cell dormancy. Mol Oncol (2016) 0.75
Hypoxia and Bone Metastatic Disease. Curr Osteoporos Rep (2017) 0.75
Downregulation of estrogen receptor and modulation of growth of breast cancer cell lines mediated by paracrine stromal cell signals. Breast Cancer Res Treat (2016) 0.75
Bone morphogenetic proteins, breast cancer, and bone metastases: striking the right balance. Endocr Relat Cancer (2017) 0.75
Mouse models of metastasis: progress and prospects. Dis Model Mech (2017) 0.75
Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17
A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med (2002) 58.15
The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell (2008) 46.08
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet (2005) 29.45
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev (2003) 20.77
Genes that mediate breast cancer metastasis to lung. Nature (2005) 19.85
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet (2008) 17.67
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell (2007) 14.87
Endogenous human microRNAs that suppress breast cancer metastasis. Nature (2008) 14.37
Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer (2009) 14.17
Tumor metastasis: molecular insights and evolving paradigms. Cell (2011) 10.34
Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res (1992) 9.02
Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell (2009) 8.33
Genes that mediate breast cancer metastasis to the brain. Nature (2009) 8.23
Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell (2008) 7.69
TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell (2008) 7.60
Interactions between cancer stem cells and their niche govern metastatic colonization. Nature (2011) 6.94
Control of the embryonic stem cell state. Cell (2011) 6.89
The cancer stem cell: premises, promises and challenges. Nat Med (2011) 6.73
The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell (2009) 6.64
Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell (2009) 5.24
Cancer stem cells: mirage or reality? Nat Med (2009) 5.20
The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell (2011) 5.06
Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell (2011) 4.79
Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell (2006) 4.48
Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med (2011) 4.25
Transcriptome profile of human colorectal adenomas. Mol Cancer Res (2007) 3.82
Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat Med (2011) 3.82
A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell (2010) 3.43
VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors. Cancer Cell (2011) 3.23
Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev (1998) 3.16
Loss of a quiescent niche but not follicle stem cells in the absence of bone morphogenetic protein signaling. Proc Natl Acad Sci U S A (2007) 3.16
CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling. Oncogene (2011) 3.08
ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proc Natl Acad Sci U S A (2007) 2.85
Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs. Proc Natl Acad Sci U S A (2009) 2.75
Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. J Clin Invest (2009) 2.55
A mouse cerberus/Dan-related gene family. Dev Biol (1999) 1.97
The disparate role of BMP in stem cell biology. Oncogene (2005) 1.92
Extracellular BMP-antagonist regulation in development and disease: tied up in knots. Trends Cell Biol (2010) 1.56
Novel retroviral vectors to facilitate expression screens in mammalian cells. Nucleic Acids Res (2002) 1.51
NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states. Carcinogenesis (2007) 1.47
Repression of KIAA1199 attenuates Wnt-signalling and decreases the proliferation of colon cancer cells. Br J Cancer (2011) 1.32
The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation. Oncogene (2011) 1.17
Cell fate specification and competence by Coco, a maternal BMP, TGFbeta and Wnt inhibitor. Development (2003) 1.17
BMP and BMP receptor expression during murine organogenesis. Gene Expr Patterns (2009) 1.13
Genetic complementation of cytokine signaling identifies central role of kinases in hematopoietic cell proliferation. Oncogene (2004) 0.95
Integrated genomic characterization of endometrial carcinoma. Nature (2013) 14.29
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci U S A (2003) 13.68
Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med (2003) 12.94
WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development. Cell (2005) 8.86
In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science (2002) 8.80
Autoantibody signatures in prostate cancer. N Engl J Med (2005) 7.56
A randomized prospective multicenter trial of pancreaticoduodenectomy with and without routine intraperitoneal drainage. Ann Surg (2014) 7.08
Integrin signalling during tumour progression. Nat Rev Mol Cell Biol (2004) 6.53
Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program. Cancer Res (2004) 5.88
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med (2015) 5.71
A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell (2012) 4.89
Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell (2006) 4.48
Integrative genomics analysis reveals silencing of beta-adrenergic signaling by polycomb in prostate cancer. Cancer Cell (2007) 4.43
Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest (2006) 4.37
Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med (2011) 4.25
Subtle variations in Pten dose determine cancer susceptibility. Nat Genet (2010) 4.19
Molecular signature of human embryonic stem cells and its comparison with the mouse. Dev Biol (2003) 3.95
Neural induction, the default model and embryonic stem cells. Nat Rev Neurosci (2002) 3.53
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat Genet (2011) 3.41
Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer. Mod Pathol (2007) 3.37
Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma. Cell (2013) 3.33
Loss of the tumor suppressor gene NF2, encoding merlin, constitutively activates integrin-dependent mTORC1 signaling. Mol Cell Biol (2009) 3.25
Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol Cell (2007) 3.23
Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. N Engl J Med (2013) 3.21
Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer. J Clin Invest (2009) 3.14
Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer. Genes Dev (2011) 3.04
The miR-430/427/302 family controls mesendodermal fate specification via species-specific target selection. Dev Cell (2009) 3.01
Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol (2010) 2.97
Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation. Proc Natl Acad Sci U S A (2009) 2.86
ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proc Natl Acad Sci U S A (2007) 2.85
Comparative genomic analysis of primary versus metastatic colorectal carcinomas. J Clin Oncol (2012) 2.74
Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases. Cancer Res (2007) 2.60
Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. J Clin Invest (2009) 2.55
Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis. Cancer Res (2005) 2.55
Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancers. Clin Cancer Res (2012) 2.52
Changes in differential gene expression because of warm ischemia time of radical prostatectomy specimens. Am J Pathol (2002) 2.50
Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus. Cell (2010) 2.38
Breast cancer methylomes establish an epigenomic foundation for metastasis. Sci Transl Med (2011) 2.33
The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving therapy. Ann Surg (2010) 2.26
FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development. EMBO J (2004) 2.24
Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis. Ann Surg Oncol (2007) 2.19
Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res (Phila) (2011) 2.09
Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J (2005) 2.04
Prognostic immune markers in non-small cell lung cancer. Clin Cancer Res (2011) 2.03
Signaling pathways in cancer and embryonic stem cells. Stem Cell Rev (2007) 2.01
Positional signaling mediated by a receptor-like kinase in Arabidopsis. Science (2004) 1.98
High expression levels of total IGF-1R and sensitivity of NSCLC cells in vitro to an anti-IGF-1R antibody (R1507). PLoS One (2009) 1.93
DRAGON, a bone morphogenetic protein co-receptor. J Biol Chem (2005) 1.89
Contribution of human embryonic stem cells to mouse blastocysts. Dev Biol (2006) 1.88
Merlin/NF-2 mediates contact inhibition of growth by suppressing recruitment of Rac to the plasma membrane. J Cell Biol (2005) 1.86
Shedding light on Merlin's wizardry. Trends Cell Biol (2007) 1.85
Integrin beta4 signaling promotes tumor angiogenesis. Cancer Cell (2004) 1.83
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma. Cancer Cell (2016) 1.79
Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate (2006) 1.78
A regulatory circuitry comprised of miR-302 and the transcription factors OCT4 and NR2F2 regulates human embryonic stem cell differentiation. EMBO J (2010) 1.77
Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up. J Clin Oncol (2008) 1.75
Contemporary results of surgical resection of non-small cell lung cancer after induction therapy: a review of 549 consecutive cases. J Thorac Oncol (2011) 1.69
Intracystic papillary carcinoma of the breast: An in situ or invasive tumor? Results of immunohistochemical analysis and clinical follow-up. Am J Surg Pathol (2011) 1.68
Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways. J Biol Chem (2006) 1.63
IDH mutation and neuroglial developmental features define clinically distinct subclasses of lower grade diffuse astrocytic glioma. Clin Cancer Res (2012) 1.61
Pattern discovery and cancer gene identification in integrated cancer genomic data. Proc Natl Acad Sci U S A (2013) 1.60
Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. Int J Radiat Oncol Biol Phys (2010) 1.60
An efficient and reversible transposable system for gene delivery and lineage-specific differentiation in human embryonic stem cells. Cell Stem Cell (2009) 1.59
Reassessment of id1 protein expression in human mammary, prostate, and bladder cancers using a monospecific rabbit monoclonal anti-id1 antibody. Cancer Res (2006) 1.56
HER-2/neu status is a determinant of mammary aromatase activity in vivo: evidence for a cyclooxygenase-2-dependent mechanism. Cancer Res (2006) 1.55
Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys (2010) 1.52
Unique players in the BMP pathway: small C-terminal domain phosphatases dephosphorylate Smad1 to attenuate BMP signaling. Proc Natl Acad Sci U S A (2006) 1.52
A latent variable approach for meta-analysis of gene expression data from multiple microarray experiments. BMC Bioinformatics (2007) 1.48
Distinct clinical course of EGFR-mutant resected lung cancers: results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib. J Thorac Oncol (2012) 1.46
Targeted deletion of the integrin beta4 signaling domain suppresses laminin-5-dependent nuclear entry of mitogen-activated protein kinases and NF-kappaB, causing defects in epidermal growth and migration. Mol Cell Biol (2005) 1.44
Proposal of a model of mammalian neural induction. Dev Biol (2007) 1.42
Netrin-integrin signaling in epithelial morphogenesis, axon guidance and vascular patterning. Cell Cycle (2005) 1.42
Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas. Clin Cancer Res (2009) 1.42
GDF3, a BMP inhibitor, regulates cell fate in stem cells and early embryos. Development (2005) 1.40
Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer. Cancer (2010) 1.40
An oncogenic isoform of HER2 associated with locally disseminated breast cancer and trastuzumab resistance. Mol Cancer Ther (2009) 1.39
Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells. Am J Surg Pathol (2003) 1.37
EGF-CFC proteins are essential coreceptors for the TGF-beta signals Vg1 and GDF1. Genes Dev (2003) 1.37
APCDD1 is a novel Wnt inhibitor mutated in hereditary hypotrichosis simplex. Nature (2010) 1.35
Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutations. J Thorac Oncol (2011) 1.34
Erlotinib resistance in mouse models of epidermal growth factor receptor-induced lung adenocarcinoma. Dis Model Mech (2009) 1.34
Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death. Cancer Epidemiol Biomarkers Prev (2005) 1.33
Prostaglandin E2 regulates tumor angiogenesis in prostate cancer. Cancer Res (2008) 1.31
Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus. EMBO Rep (2012) 1.30
Integrative subtype discovery in glioblastoma using iCluster. PLoS One (2012) 1.29
A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer. Clin Cancer Res (2008) 1.25
Compartmentalization of integrin alpha6beta4 signaling in lipid rafts. J Cell Biol (2003) 1.23
Gene profiling during neural induction in Xenopus laevis: regulation of BMP signaling by post-transcriptional mechanisms and TAB3, a novel TAK1-binding protein. Development (2002) 1.23
Dynamics of TGF-β signaling reveal adaptive and pulsatile behaviors reflected in the nuclear localization of transcription factor Smad4. Proc Natl Acad Sci U S A (2012) 1.23
Automated tracking and analysis of centrosomes in early Caenorhabditis elegans embryos. Bioinformatics (2010) 1.21
Desmoid tumors (fibromatoses) of the breast: a 25-year experience. Ann Surg Oncol (2007) 1.21
Oleic acid and peanut oil high in oleic acid reverse the inhibitory effect of insulin production of the inflammatory cytokine TNF-alpha both in vitro and in vivo systems. Lipids Health Dis (2009) 1.21
Lefty blocks a subset of TGFbeta signals by antagonizing EGF-CFC coreceptors. PLoS Biol (2004) 1.19
Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations. Genome Biol (2014) 1.19